[1]
C. Rusconi, “Treatment of very high-risk classical Hodgkin Lymphoma: cases’ selection from real life and critical review of the literature ”, Acta Biomed, vol. 91, no. S-5, pp. 13–22, May 2020, doi: 10.23750/abm.v91iS-5.9911.